Africa CDC Study: How SMS Reminders Boost Treatment Success for TB Patients
The Africa Centres for Disease Control and Prevention (Africa CDC) has launched a new study. This research explores using mobile phone messaging. They want to improve SMS reminders boost treatment adherence for tuberculosis (TB). Ethiopia and Liberia are two of the most affected nations. Adherence to TB medication is a persistent challenge. The World Bank provided a US$100,000 grant for the study. It runs from November 17 to December 12, 2025.
Why Adherence Matters
TB remains a major global health challenge. In 2023, about 10.8 million people worldwide were infected. This resulted in over 1.25 million deaths. Ethiopia and Liberia have very high rates of infection. Poor adherence to TB medication is a serious issue. As a result, this can cause treatment failure and drug resistance. The Africa CDC is actively leveraging digital technology. The study aims to improve adherence using simple SMS reminders. It also identifies barriers to using digital tools.
How the Study Works
The project involves two key phases. First, a baseline assessment measures current adherence. Second, a pilot intervention uses SMS reminders for those struggling. A total of 844 TB patients will participate in the study. Specifically, 422 participants are in Ethiopia and 422 are in Liberia. Roughly 200 people will receive the SMS reminders boost treatment messages. Dr. Mosoka Fallah calls this research “significant.” He notes it integrates digital innovation into African TB care. This approach advances patient-centered solutions.
Informing Future Strategies
The study is being carried out with Ministries of Health. It also partners with universities in Ethiopia and Liberia. This important research helps Member States. The insights gained will inform national TB strategies. Furthermore, they will guide continental policy recommendations. Dr. Fallah stated that Africa CDC prioritises implementation science. The initiative contributes to the broader digital health agenda in Africa. Ultimately, these findings aim to strengthen TB control programs everywhere. This work aligns with the WHO End-TB Strategy.
